Search Results - "Bompoint S"

Lack of impact of ipragliflozin on endothelial function in patients with type 2 diabetes: sub-analysis of the PROTECT study.

Authors: Kishimoto, Shinji Higashi, Yukihito Imai, Takumi et al.

Source: Cardiovascular Diabetology. 5/20/2023, Vol. 22 Issue 1, p1-9. 9p.

2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC

Authors: McDonagh, Theresa A. Metra, Marco Adamo, Marianna et al.

Source: European Journal of Heart Failure. Jan2024, Vol. 26 Issue 1, p5-17. 13p.

Review of the target trial methodological approach on treatment effect estimates in kidney failure: protocol for a systematic assessment.

Authors: Pinter, Jule Tunnicliffe, David J. Karunikaikumar, Pooshwikaa et al.

Source: Systematic Reviews. 11/14/2024, Vol. 13 Issue 1, p1-6. 6p.

Effects of SGLT2 Inhibitors on Proteinuria and Renal Function Parameters in Non-Diabetic Kidney Transplant Recipients: A Retrospective Cohort Study Based on 12-Month Follow-Up Data.

Authors: Kahvecioglu, Serdar Celik, Huseyin Karatutlu, Asena Serap et al.

Source: Journal of Clinical Medicine. Jul2026, Vol. 15 Issue 13, p5303. 10p.

Inhibition of SGLT2 reduces blood pressure in the early phase of salt‐sensitive hypertension in male Dahl‐SS rats independently of changes in renal inflammation.

Authors: Almutlaq, Rawan N. Srisomboon, Yotesawee Guntipally, Sridhatri et al.

Source: Physiological Reports. Jul2026, Vol. 14 Issue 13, p1-16. 16p.

Protocol for Developing and Validating a Multimarker-Clinical Prediction Model of SGLT2 Inhibitor-Induced Acute eGFR Dip in CKD Stages 3–4: A Three-Stage Urinary Proteomics Study.

Authors: Duan, Zhiyu Gao, Youhe Huang, Mengjie et al.

Source: Life (2075-1729). Jun2026, Vol. 16 Issue 6, p865. 17p.

Zinc Potentiates the Renoprotective Effects of SGLT2 Inhibitors in Experimental Diabetes Mellitus in Rats.

Authors: Anton, Irina Claudia Solcan, Carmen Mititelu Tartau, Liliana et al.

Source: Life (2075-1729). May2026, Vol. 16 Issue 5, p793. 28p.

BMI Category and Survival in Incident Hemodialysis Patients: The Overweight Advantage in an Eastern European Cohort.

Authors: Motofelea, Alexandru Catalin Olariu, Nicu Pecingina, Radu et al.

Source: Journal of Clinical Medicine. Apr2026, Vol. 15 Issue 8, p2856. 17p.

THE EFFECT OF SGLT-2 INHIBITORS ON HEMOGLOBIN AND HEMATOCRIT LEVELS IN PATIENTS WITH TYPE 2 DIABETES: A RETROSPECTIVE REAL-WORLD ANALYSIS.

Authors: Turunç, Ali Saday Bozkurt, Melike

Source: AFMN Biomedicine. 2026, Vol. 43 Issue 2, p171-177. 7p.

Once-Weekly Semaglutide in Patients with Cardiovascular-Kidney-Metabolic Syndrome: A Real-World Study.

Authors: Trenas-Calero, Alicia Prieto-Laín, Nuria Gómez-Hernández, Ana I. et al.

Source: Pharmaceuticals (14248247). Apr2026, Vol. 19 Issue 4, p583. 13p.

Predicting Lifetime Risk of Kidney Failure Using Age and a Single eGFR Measurement.

Authors: Enoki, Ryo Miyazaki, Mariko Imai, Enyu et al.

Source: Journal of Clinical Medicine. Apr2026, Vol. 15 Issue 7, p2653. 14p.

Gastric Neoplasm Risk with DPP-4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors: Network Meta-Analysis of Randomized Trials.

Authors: Hung, Chao-Ming Hsu, Chih-Wei Zeng, Bing-Syuan et al.

Source: International Journal of Molecular Sciences. Mar2026, Vol. 27 Issue 6, p2619. 21p.

Dynamics and Predictive Values of Urinary Podocyte Biomarkers Following SGLT2 Inhibition in CKD.

Authors: Urs, Alexandra Moldovan, Diana Rusu, Crina Claudia et al.

Source: Life (2075-1729). Mar2026, Vol. 16 Issue 3, p529. 17p.

New Insights into Kidney Diseases.

Authors: Katayama, Kan Dohi, Kaoru

Source: International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 23, p12536. 3p.

Type 2 diabetes, sodium-glucose cotransporter-2 inhibitors and cardiovascular outcomes: real world evidence versus a randomised clinical trial.

Authors: Yazdanfard, Puriya Daniel Würtz Sørensen, Kathrine Kold Zareini, Bochra et al.

Source: Cardiovascular Diabetology. 9/30/2025, Vol. 24 Issue 1, p1-12. 12p.

Buffered salt solution versus 0.9% sodium chloride as fluid therapy for patients presenting with moderate to severe diabetic ketoacidosis: Study protocol for a Phase-3 cluster-crossover, blinded, randomised, controlled trial.

Authors: Ramanan M Rajbhandari D Koch C et al.

Source: Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine [Crit Care Resusc] 2025 Mar 13; Vol. 27 (1), pp. 100104. Date of Electronic Publication: 2025 Mar 13 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier B.V. on behalf of College of Intensive Care Medicine of Australia and New Zealand Country of Publication: Netherlands NLM ID: 100888170 Publication Model: eCollection Cited Medium: Print ISSN: 1441-2772 (Print) Linking ISSN: 14412772 NLM ISO Abbreviation: Crit Care Resusc Subsets: PubMed not MEDLINE

Heart failure outcomes captured by adverse event reporting in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial.

Authors: Pandey, Ambarish Kolkailah, Ahmed A. McGuire, Darren K. et al.

Source: European Journal of Heart Failure. Mar2025, Vol. 27 Issue 3, p521-526. 6p.

Agent- and Dose-Specific Intestinal Obstruction Safety of GLP-1 Receptor Agonists and SGLT2 Inhibitors: A Network Meta-Analysis of Randomized Trials.

Authors: Chen, Jiann-Jy Hsu, Chih-Wei Hung, Chao-Ming et al.

Source: International Journal of Molecular Sciences. Jan2026, Vol. 27 Issue 2, p608. 27p.

Association Between Sodium–Glucose Cotransporter‐2 Inhibitors and Sepsis Risk in Patients With Type 2 Diabetes Mellitus.

Authors: Wu, Chun-Ying Lai, Chih-Cheng Ho, Chung-Han et al.

Source: Journal of Diabetes Research. 1/8/2026, Vol. 2026, p1-10. 10p.

Sodium-Glucose Transport Protein-2 Inhibitors in the Treatment of Non-alcoholic Steatohepatitis: An Evidence-Based Review.

Authors: Lv, Xueyan Mi, Dianchao Mi Xin, Yuhang et al.

Source: Hepatitis Monthly. Dec2025, Vol. 25 Issue 1, p1-8. 8p.